Vv Manager is an investment fund managing more than $114 million ran by Fred Cohen. There are currently 4 companies in Mr. Cohen’s portfolio. The largest investments include Allogene Therapeutics and Oyster Point Pharma, together worth $99.5 million.
As of 7th October 2020, Vv Manager’s top holding is 1,798,163 shares of Allogene Therapeutics currently worth over $77 million and making up 67.5% of the portfolio value.
Relative to the number of outstanding shares of Allogene Therapeutics, Vv Manager owns more than approximately 0.1% of the company.
In addition, the fund holds 778,468 shares of Oyster Point Pharma worth $22.5 million, whose value fell 22.3% in the past six months.
The third-largest holding is Homology Medicines worth $11.7 million and the next is Sutro Biopharma worth $2.84 million, with 365,656 shares owned.
Currently, Vv Manager's portfolio is worth at least $114 million. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Vv Manager office and employees reside in Boston, Massachusetts. According to the last 13-F report filed with the SEC, Fred Cohen serves as the Senior Managing Director at Vv Manager.
In the most recent 13F filing, Vv Manager revealed that it had opened a new position in
Oyster Point Pharma and bought 778,468 shares worth $22.5 million.
On the other hand, there are companies that Vv Manager is getting rid of from its portfolio.
Vv Manager closed its position in Oyster Point Pharma on 4th August 2020.
It sold the previously owned 963,468 shares for $23.5 million.
Fred Cohen also disclosed a decreased stake in Allogene Therapeutics by 0.4%.
This leaves the value of the investment at $77 million and 1,798,163 shares.
The two most similar investment funds to Vv Manager are Sycale Advisors (ny) and Yong Rong (hk) Asset Management Ltd. They manage $114 million and $114 million respectively.
Vv Manager’s portfolio is diversified across 1 sector.
Currently, their heaviest sector is Health Care — making up 100.0% of
the total portfolio value.
The fund focuses on investments in the United States as
100.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
approximately 0.1% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $1.54 billion.
These positions were updated on August 4th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Allogene Therapeutics, Inc. |
37.77%
1,798,163
|
$76,997,000 | 67.53% |
| Oyster Point Pharma, Inc. |
Closed
963,468
|
$23,547,000 | |
| Oyster Point Pharma, Inc. |
Opened
778,468
|
$22,482,000 | 19.72% |
| Homology Medicines, Inc. |
No change
770,845
|
$11,709,000 | 10.27% |
| Sutro Biopharma, Inc. |
63.27%
365,656
|
$2,837,000 | 2.49% |
| No transactions found | |||
| Showing first 500 out of 5 holdings | |||